Moulid Hidayat

569 total citations
21 papers, 330 citations indexed

About

Moulid Hidayat is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Moulid Hidayat has authored 21 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Moulid Hidayat's work include Public Health and Nutrition (5 papers), COVID-19 Prevention and Impact (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Moulid Hidayat is often cited by papers focused on Public Health and Nutrition (5 papers), COVID-19 Prevention and Impact (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Moulid Hidayat collaborates with scholars based in Indonesia, Japan and China. Moulid Hidayat's co-authors include Kazuhisa Takahashi, Fumiyuki Takahashi, Wira Winardi, Fariz Nurwidya, Shinichi Sasaki, Ken Tajima, Agus Dwi Susanto, Akiko Murakami, Isao Kobayashi and Naoko Shimada and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Respiratory Research and Drug Design Development and Therapy.

In The Last Decade

Moulid Hidayat

16 papers receiving 328 citations

Peers

Moulid Hidayat
Xue Du China
Xuyou Zhu China
Manabu Ono Japan
Parisa Ghaffari Iran
Till Plönes Germany
Silvia Vidal-Millán Mexico
Rebecca Teske United States
Santiyagu M. Savarimuthu Francis Australia
Timo Effenberger Germany
Xue Du China
Moulid Hidayat
Citations per year, relative to Moulid Hidayat Moulid Hidayat (= 1×) peers Xue Du

Countries citing papers authored by Moulid Hidayat

Since Specialization
Citations

This map shows the geographic impact of Moulid Hidayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moulid Hidayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moulid Hidayat more than expected).

Fields of papers citing papers by Moulid Hidayat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moulid Hidayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moulid Hidayat. The network helps show where Moulid Hidayat may publish in the future.

Co-authorship network of co-authors of Moulid Hidayat

This figure shows the co-authorship network connecting the top 25 collaborators of Moulid Hidayat. A scholar is included among the top collaborators of Moulid Hidayat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moulid Hidayat. Moulid Hidayat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mitsuishi, Yoichiro, Wira Winardi, Moulid Hidayat, et al.. (2024). Anti‐Müllerian hormone type II receptor protein expression in non‐small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation. Thoracic Cancer. 15(29). 2090–2099. 1 indexed citations
3.
4.
Hidayat, Moulid, et al.. (2023). SEMINAR AWAM: KENALI ASMA DAN TANGANI DENGAN TEPAT. 4(1). 49–52.
5.
Winardi, Wira, et al.. (2022). Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective. Narra J. 2(2). e80–e80. 16 indexed citations
6.
Hidayat, Moulid. (2022). BATAVIA KECIL DIBUMI RAFFLESIA (Potret kehidupan penambang emas di Desa Lebong Tandai). 3(2). 61–70. 1 indexed citations
7.
Susanto, Agus Dwi, et al.. (2021). Lung Fibrosis Sequelae After Recovery from COVID-19 Infection. The Journal of Infection in Developing Countries. 15(3). 360–365. 8 indexed citations
8.
Nurwidya, Fariz, et al.. (2021). INTERLEUKIN-6 DAN POTENSI TERAPI INHIBISI INTERLEUKIN-6 DALAM TATA LAKSANA COVID-19. Unram Medical Journal. 10(3). 537–541.
9.
10.
Hidayat, Moulid, Diah Handayani, Fariz Nurwidya, & Sita Andarini. (2021). Hyperinflammation Syndrome in COVID-19 Disease: Pathogenesis and Potential Immunomodulatory Agents. 3 indexed citations
11.
Susanto, Agus Dwi, et al.. (2020). The use of indoor plant as an alternative strategy to improve indoor air quality in Indonesia. Reviews on Environmental Health. 36(1). 95–99. 24 indexed citations
12.
Kato, Motoyasu, Fumiyuki Takahashi, Tadashi Sato, et al.. (2020). <p>Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 Pathway</p>. Drug Design Development and Therapy. Volume 14. 4593–4603. 20 indexed citations
13.
Hayakawa, Daisuke, Fumiyuki Takahashi, Yoichiro Mitsuishi, et al.. (2019). Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation. Thoracic Cancer. 11(1). 140–149. 41 indexed citations
14.
Takahashi, Fumiyuki, Motoyasu Kato, Yoichiro Mitsuishi, et al.. (2018). Dasatinib Suppresses TGFβ-Mediated Epithelial–Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis. Lung. 196(5). 531–541. 20 indexed citations
15.
16.
Yagishita, Shigehiro, Ken Tajima, Fumiyuki Takahashi, et al.. (2016). LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer. Biochemistry and Biophysics Reports. 9. 86–94. 10 indexed citations
17.
Kobayashi, Isao, Fumiyuki Takahashi, Fariz Nurwidya, et al.. (2016). Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells. Biochemical and Biophysical Research Communications. 473(1). 125–132. 44 indexed citations
18.
Nurwidya, Fariz, Fumiyuki Takahashi, Isao Kobayashi, et al.. (2014). Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial–mesenchymal transition in non-small cell lung cancer. Biochemical and Biophysical Research Communications. 455(3-4). 332–338. 36 indexed citations
19.
Nurwidya, Fariz, et al.. (2014). Possible strategies for future tobacco reduction policy in Indonesia. Epidemiology and Health. 36. e2014035–e2014035. 2 indexed citations
20.
Hoof, Ambro van, et al.. (1995). Mediastinal B-Cell Lymphoma with Sclerosis:Clinical Features and Treatment Results in 10 Patients. Acta Clinica Belgica. 50(3). 137–143. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue Du Breakdown of academic impact, for papers by Xuyou Zhu Breakdown of academic impact, for papers by Manabu Ono Breakdown of academic impact, for papers by Parisa Ghaffari Breakdown of academic impact, for papers by Till Plönes Breakdown of academic impact, for papers by Silvia Vidal-Millán Breakdown of academic impact, for papers by Rebecca Teske Breakdown of academic impact, for papers by Santiyagu M. Savarimuthu Francis Breakdown of academic impact, for papers by Timo Effenberger
Rankless by CCL
2026